Indication

Locally advanced breast carcinoma

Locally advanced breast carcinoma refers to an aggressive, invasive epithelial malignancy arising within breast glandular tissue that exhibits extensive locoregional extension without evidence of distant metastasis. Read more about Locally advanced breast carcinoma

98 drugs 61 manufacturers

Advertisement

Drugs that treat it

Common Locally advanced breast carcinoma therapies.

Showing 10–18 of 98 drugs

EPIRUBICIN HCL

LOCALLY ADVANCED BREAST CARCINOMA
Teva Parenteral Medicines

PACLITAXEL

ANTINEOPLASTIC - TAXANES·KAPOSI'S SARCOMA·+5
HOSPIRA
Filter & compare in the drug finder →Opens the drug finder with Locally advanced breast carcinoma preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Locally advanced breast carcinoma.

Locally advanced breast carcinoma refers to an aggressive, invasive epithelial malignancy arising within breast glandular tissue that exhibits extensive locoregional extension without evidence of distant metastasis.

Primarily affecting adult women, it encompasses AJCC stage III disease (including stages IIIA, IIIB, and IIIC) and select high-risk stage IIB presentations.

Defining clinicopathologic features include primary tumors exceeding 5 centimeters, extensive direct invasion into the overlying skin or underlying chest wall, inflammatory breast carcinoma morphology, or heavy regional nodal involvement such as matted axillary, internal mammary, or supraclavicular lymphadenopathy.

Personalize your experience

Follow Locally advanced breast carcinoma and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it